Consun Pharmaceutical Group Limited (FRA:C1P)
Germany flag Germany · Delayed Price · Currency is EUR
1.860
+0.030 (1.64%)
At close: Jan 30, 2026

FRA:C1P Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,2432,9082,7482,4502,1961,940
Short-Term Investments
1,794958834.94589.17230-
Cash & Short-Term Investments
4,0373,8663,5833,0392,4261,940
Cash Growth
12.73%7.88%17.89%25.26%25.05%40.27%
Accounts Receivable
296.34297.57255.84259.56351.23448.54
Other Receivables
98.2172.5554.1336.118.349.89
Receivables
394.55370.12309.97295.66369.57458.43
Inventory
286.7315.51384.91287.66257.62227.37
Restricted Cash
4.37---2.32-
Other Current Assets
43.47----32.62
Total Current Assets
4,7664,5514,2783,6233,0562,659
Property, Plant & Equipment
915.2925.54863.71875858.45799.45
Long-Term Investments
63.3129.089.236.5--
Other Intangible Assets
267.28268.96283.14311.9341.66371.42
Long-Term Deferred Tax Assets
14.712.5217.8436.4346.8658.89
Other Long-Term Assets
66.1165.6755.9939.8759.9461.8
Total Assets
6,0935,8535,5084,8924,3633,950
Accounts Payable
96.8675.6483.159.8966.6450.89
Accrued Expenses
777.19736.12638.76566.13465.53406.42
Current Portion of Long-Term Debt
239.28253.34503.42450.52599.3549.41
Current Portion of Leases
9.496.424.223.713.12-
Current Income Taxes Payable
45.7347.6343.3832.892.5471.11
Current Unearned Revenue
52.7660.8217.5639.9821.2115.49
Other Current Liabilities
126.83190.83204.57197.37199.07238.55
Total Current Liabilities
1,3481,3711,4951,3501,3571,332
Long-Term Leases
4.587.413.95.958.55-
Long-Term Unearned Revenue
13.7914.6419.1818.9316.715.63
Long-Term Deferred Tax Liabilities
80.0367.1971.2178.0169.386.26
Total Liabilities
1,4471,4601,5891,4531,4521,434
Common Stock
67.5867.3163.8163.4564.864.42
Additional Paid-In Capital
-216.4618.15-19.79-
Retained Earnings
-3,6503,3812,9132,3932,003
Treasury Stock
---83.17-83.17-113.32-88.64
Comprehensive Income & Other
4,283163.67247.15251.7253.89241.38
Total Common Equity
4,3504,0983,6273,1452,6182,220
Minority Interest
296.32295.45292.21293.87293.08296.13
Shareholders' Equity
4,6464,3933,9193,4392,9112,516
Total Liabilities & Equity
6,0935,8535,5084,8924,3633,950
Total Debt
253.35267.17511.53460.18610.97549.41
Net Cash (Debt)
3,7843,5993,0722,5791,8151,391
Net Cash Growth
23.43%17.15%19.10%42.08%30.52%67.64%
Net Cash Per Share
4.434.323.843.262.261.70
Filing Date Shares Outstanding
850.33830.83792.43788.39805.64799.83
Total Common Shares Outstanding
850.33830.83792.43788.39805.64799.83
Working Capital
3,4183,1812,7832,2721,6981,327
Book Value Per Share
5.124.934.583.993.252.78
Tangible Book Value
4,0833,8293,3432,8332,2761,849
Tangible Book Value Per Share
4.804.614.223.592.832.31
Buildings
-399.2338.28334.82334.1333.15
Machinery
-363.52324.86302.16282.15269
Construction In Progress
-412.24416.43416.01381.67314.65
Source: S&P Global Market Intelligence. Standard template. Financial Sources.